News

News 2017-10-16T13:45:39+00:00
Jan2018

New $2.7m contract in progressive supranuclear palsy with a global pharmaceutical company

30 January 2018|Categories: Contracts|

IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces that it has signed an additional new contract with an existing global pharmaceutical customer. The contract value is $2.7m, over a seven year term, to commence immediately.

IXICO will provide its technology enabled imaging services in a clinical trial of a novel therapeutic to treat people with progressive supranuclear palsy (‘PSP’), a rare neurodegenerative disease.

PRESS RELEASE
Jan2018

Results of AGM

22 January 2018|Categories: Financial|

IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed. PRESS RELEASE

Jan2018

AGM Statement and Board Chages

22 January 2018|Categories: Financial|

Building scale and momentum with commercially-led growth IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, will hold its Annual General Meeting at 9.30am today at the offices of FTI Consulting LLP, 200 [...]

Dec2017

IXICO plc Annual Report & Accounts 2017

15 December 2017|Categories: Financial|

Strong revenue growth and reduced operating losses as momentum builds IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today releases its Annual Report for the year ended 30 September 2017. ANNUAL REPORT [...]

Nov2017

Strategic and Operational Update

28 November 2017|Categories: IXICO|

Building scale and momentum with commercially-led growth Notice of Final results IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today outlines its commercially led growth strategy as defined by Giulio Cerroni, Chief [...]

Nov2017

IXICO signs its first contract with a new biopharma customer to deploy biosensors in a late stage clinical trial for a psychiatric disorder

21 November 2017|Categories: Contracts|

Further expansion of IXICO's biopharma customer base and wearable biosensor technology IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces that it has signed a new contract with another leading biopharmaceutical company [...]

Load More Posts